94 related articles for article (PubMed ID: 23339364)
1. Expression of multidrug resistance 1 gene in B-cell lymphomas: association with follicular dendritic cells.
Yagi K; Yamamoto K; Umeda S; Abe S; Suzuki S; Onishi I; Kirimura S; Fukayama M; Arai A; Kitagawa M; Kurata M
Histopathology; 2013 Feb; 62(3):414-20. PubMed ID: 23339364
[TBL] [Abstract][Full Text] [Related]
2. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
3. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma.
Vermi W; Lonardi S; Bosisio D; Uguccioni M; Danelon G; Pileri S; Fletcher C; Sozzani S; Zorzi F; Arrigoni G; Doglioni C; Ponzoni M; Facchetti F
J Pathol; 2008 Nov; 216(3):356-64. PubMed ID: 18792075
[TBL] [Abstract][Full Text] [Related]
4. γ-Synuclein is a promising new marker for staining reactive follicular dendritic cells, follicular dendritic cell sarcoma, Kaposi sarcoma, and benign and malignant vascular tumors.
Zhang H; Maitta RW; Bhattacharyya PK; Florea AD; Sen F; Wang Q; Ratech H
Am J Surg Pathol; 2011 Dec; 35(12):1857-65. PubMed ID: 21959308
[TBL] [Abstract][Full Text] [Related]
5. Disappearance of CD21-positive follicular dendritic cells preceding the transformation of follicular lymphoma: immunohistological study of the transformation using CD21, p53, Ki-67, and P-glycoprotein.
Shiozawa E; Yamochi-Onizuka T; Yamochi T; Yamamoto Y; Naitoh H; Kawakami K; Nakamaki T; Tomoyasu S; Kushima M; Ota H
Pathol Res Pract; 2003; 199(5):293-302. PubMed ID: 12908519
[TBL] [Abstract][Full Text] [Related]
6. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
7. Follicular lymphoma of the skin and superficial soft tissues associated with a prominent follicular dendritic cell proliferation: an unusual pattern which may represent a diagnostic pitfall.
Kazakov DV; Palmedo G; Mukensnabl P; Hes O; Kempf W; Michal M
Pathol Res Pract; 2004; 200(7-8):557-65. PubMed ID: 15462504
[TBL] [Abstract][Full Text] [Related]
8. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
[TBL] [Abstract][Full Text] [Related]
9. Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases.
Kojima M; Nakamura S; Ichimura K; Suzuki R; Kagami Y; Kondo E; Motoori T; Hosomura Y; Oyama T; Itoh H; Ban S; Yoshida K; Ohno Y; Shimizu K; Masawa N; Sugihara S
Mod Pathol; 2002 Jul; 15(7):750-8. PubMed ID: 12118113
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of estrogen receptor-α on follicular dendritic cells from patients with grade 1-2 and grade 3 follicular lymphoma.
Ohe R; Meng HX; Ye Aung N; Yamada A; Kabasawa T; Utsunomiya A; Tamazawa N; Tamura Y; Kitaoka T; Hashimoto T; Shibata K; Toubai T; Kimura W; Ishizawa K; Yamakawa M
Hematol Oncol; 2019 Apr; 37(2):151-159. PubMed ID: 30736096
[TBL] [Abstract][Full Text] [Related]
11. Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas.
Wada K; Maeda K; Tajima K; Kato T; Kobata T; Yamakawa M
Histopathology; 2009 Jan; 54(2):221-32. PubMed ID: 19207947
[TBL] [Abstract][Full Text] [Related]
12. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of Toll-like receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma.
Smith TJ; Yamamoto K; Kurata M; Yukimori A; Suzuki S; Umeda S; Sugawara E; Kojima Y; Sawabe M; Nakagawa Y; Suzuki K; Crawley JT; Kitagawa M
Exp Mol Pathol; 2010 Dec; 89(3):284-90. PubMed ID: 20800061
[TBL] [Abstract][Full Text] [Related]
14. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol.
Li L; Jiang AC; Dong P; Wang H; Xu W; Xu C
Ann Surg Oncol; 2009 May; 16(5):1421-8. PubMed ID: 19247716
[TBL] [Abstract][Full Text] [Related]
15. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
16. Reverse multidrug resistance in laryngeal cancer cells by knockdown MDR1 gene expression.
Zhigang H; Qi Z; Jugao F; Xiaohong C; Wei Z; Hong W; Hu H; Na M; Zheng Y; Demin H
J Otolaryngol Head Neck Surg; 2009 Aug; 38(4):440-8. PubMed ID: 19755084
[TBL] [Abstract][Full Text] [Related]
17. Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression.
Olejniczak SH; Hernandez-Ilizaliturri FJ; Clements JL; Czuczman MS
Clin Cancer Res; 2008 Mar; 14(5):1550-60. PubMed ID: 18316580
[TBL] [Abstract][Full Text] [Related]
18. T-independent antibody responses to T-dependent antigens: a novel follicular dendritic cell-dependent activity.
El Shikh ME; El Sayed RM; Szakal AK; Tew JG
J Immunol; 2009 Mar; 182(6):3482-91. PubMed ID: 19265126
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of MDR1, LRP, MRP, and topoisomerase IIalpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines.
Miracco C; Maellaro E; Pacenti L; Del Bello B; Valentini MA; Rubegni P; Pirtoli L; Volpi C; Santopietro R; Tosi P
Int J Oncol; 2003 Jul; 23(1):213-20. PubMed ID: 12792796
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
Dönmez Y; Gündüz U
Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
